Role of Cardiac AngioMR in Diagnosis of Cardiac and Vascular Anomalies in Adult Patients with Turner Syndrome
Role of Cardiac Magnetic Resonance Angiography (1.5-T) in the Diagnosis of Cardiac and Thoraco-abdominal Vascular Tree Anomalies in Adult Patients with Turner Syndrome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Vincenzo Rochira, Prof.
- Phone Number: 0593961829
- Email: vincenzo.rochira@unimore.it
Study Locations
-
-
-
Modena, Italy
- Recruiting
- Unit of Endocrinology of Azienda Ospedaliera-Universitaria di Modena
-
Contact:
- Vincenzo Rochira, Prof.
- Phone Number: 0593962453
- Email: vincenzo.rochira@unimore.it
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- confirmed diagnosis of Turner Syndrome
- patients underwent angioMR 1.5 T
- age > 18 years
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vascular and cardiac anomalies
Time Frame: 5 years
|
description of the main cardiovascular anomalies found by MRI at the thoracic and abdominal level anomalies in terms of supernumeray arteries and/or veins and measurement of length and diameters of main vascular tracts (e.g.
ascending, descending aorta, aortic arch, renal arteries...) or vascular congenital abnormalities
|
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Endocrine System Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Male Urogenital Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Heart Diseases
- Genetic Diseases, Inborn
- Disease
- Gonadal Disorders
- Cardiovascular Abnormalities
- Heart Defects, Congenital
- Disorders of Sex Development
- Urogenital Abnormalities
- Sex Chromosome Disorders
- Chromosome Disorders
- Sex Chromosome Disorders of Sex Development
- Congenital Abnormalities
- Syndrome
- Turner Syndrome
- Gonadal Dysgenesis
Other Study ID Numbers
Other Study ID Numbers
- 1001 (Registro Nacional Estudios Clinicos (RNEC))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.